Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial
医学
肿瘤科
黑色素瘤
内科学
临床试验
药理学
癌症研究
作者
Lev Demidov,Igor Samoylenko,Galina Kharkevich,Kristina V. Orlova,В. Моисеенко,Igor Utyashev,Daniil Stroyakovskiy,Vadim Kozlov,Anastasia Zimina,Anastasia Mochalova,Svetlana Demidova,Marina A. Lyadova,Andrey Kutkovich,Pavel Skopin,Н. В. Коваленко,Sufia Safina,Vitaliy Volkov,Yulia Semiletova,Vera Vaschenko,Nikolay Kislov
PDF的下载单位、IP信息已删除
(2025-6-4)
Copyright
Kao
Nole
GingerF
Criminology34
cdercder
柏柏
OK
VDC
丰富的草莓
小透明
Puan
Feng
yjh123
无极微光
ZhaohuaXie
Hayat
嘻嘻哈哈
MchemG
潇洒的惋清
皖公网安备34019202002308
